| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |